A.M. Palache

4.8k citations

59 papers · 3.4k indexed · h-index 33

Epidemiology top 0.5%
- Influenza Virus Research Studies 50
- Respiratory viral infections research 25
Immunology top 2%
- Immune Response and Inflammation 7
- Immunotherapy and Immune Responses 6
Modeling and Simulation top 1%
- COVID-19 epidemiological studies 9
Health top 2%
- Vaccine Coverage and Hesitancy 8
Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 9
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 7

Co-authors: W.E.P. Beyer Albert D. M. E. Osterhaus J.C. de Jong N. Masurel Guus F. Rimmelzwaan Jan Wilschut Iris A. de Bruijn G.J.M. van Scharrenburg
Cited by: Epidemiology Immunology Modeling and Simulation
Journals: Vaccine (29 papers)Virus Research (3 papers)Annals of the Rheumatic Diseases (2 papers)
Partner nations: Netherlands Belgium Switzerland

In The Last Decade

A.M. Palache

58 papers receiving 3.3k citations

Peers

Countries citing papers authored by A.M. Palache

Since Specialization

Citations

This map shows the geographic impact of A.M. Palache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Palache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Palache more than expected).

Fields of papers citing papers by A.M. Palache

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Palache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Palache. The network helps show where A.M. Palache may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A.M. Palache, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A.M. Palache Line = papers co-authored together A.M. Palache links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lessons learned from the COVID-19 pandemic for improved influenza control Vaccine ·A.M. Palache,安东尼·奥立佛-史密斯,保男村上,Charlene Hu,Steven Rockman,Marcelo Vinjoy	2023	4
2	Clinical relevance of increased antibody titres in older adults upon vaccination with squalene-adjuvanted versus non-adjuvanted influenza vaccines Vaccine ·W.E.P. Beyer,A.M. Palache,George Henry Hall Jacques,Albert D. M. E. Osterhaus	2022	3
3	Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines Vaccine ·W.E.P. Beyer,A.M. Palache,Leslie A. Reperant,George Henry Hall Jacques,Albert D. M. E. Osterhaus	2019	8
4	Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004–2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness Vaccine ·A.M. Palache,Brian Payumo,Rosalind Hollingsworth,Leo Nauweds,Choolwe Jacobs,Theodore F. Tsai,森尾博昭	2017	45
5	Seasonal influenza vaccine dose distribution in 195 countries (2004–2013): Little progress in estimated global vaccination coverage Vaccine ·A.M. Palache,L Bieler,박문포,M. SRIDEVI	2015	83
6	Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency Clinical Immunology ·Sander van Assen,Aalzen de Haan,Albert Holvast,Gerda Horst,Francois Tetero,Johanna Westra,Cees G. M. Kallenberg,Denise Telgt,A.M. Palache,Эркинов Ш. Б.,Marc Bijl	2011	22
7	Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis Vaccine ·Kristina Saldūnaitė-Mikučionienė,J. J. P. Nauta,A.M. Palache,Эркинов Ш. Б.,A.D.M.E. Osterhaus	2011	62
8	Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis Annals of the Rheumatic Diseases ·Albert Holvast,Aalzen de Haan,Sander van Assen,Coen A. Stegeman,Minke G. Huitema,Anke Huckriede,C. A. Benne,Johanna Westra,A.M. Palache,Jan Wilschut,C. G. M. Kallenberg,Marc Bijl	2009	14
9	Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity Vaccine ·Эркинов Ш. Б.,Dewi Ariefahnoor,Iris A. de Bruijn,A.M. Palache	2009	14
10	Antibody and cell-mediated responses to influenza vaccination in patients with systemic lupus erythematosus and, healthy controls Data Archiving and Networked Services (DANS) ·Albert Holvast,Sander van Assen,Aalzen de Haan,Anke Huckriede,Jan Wilschut,Heui-su Ryu,Johanna Westra,Cees G. M. Kallenberg,A.M. Palache,Muhammet Furkan Karakaya	2008	0
11	Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination Annals of the Rheumatic Diseases ·Albert Holvast,Coen A. Stegeman,C. A. Benne,Anke Huckriede,Jan Wilschut,A.M. Palache,C. G. M. Kallenberg,Marc Bijl	2008	52
12	The virosomal influenza vaccine Invivac®: Immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad®) in elderly subjects Vaccine ·Iris A. de Bruijn,J. J. P. Nauta,Lisya Gerez,A.M. Palache	2006	47
13	Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply Virus Research ·Jan Paul Medema,York Zoellner,James A. Ryan,A.M. Palache	2004	23
14	Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers Virus Research ·Iris A. de Bruijn,J. J. P. Nauta,Lisya Gerez,A.M. Palache	2004	35
15	Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine Vaccine ·John Oxford,Ali A. Al‐Jabri,Rob Lambkin‐Williams,A.M. Palache,Douglas Fleming	2003	12
16	Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial The Lancet ·Iain Stephenson,Karl G. Nicholson,L S Lloyd,Robert Mischler,Robert W. Newman,A.M. Palache,Neville Q. Verlander,Fiona Warburton,John Wood,Maria Zambon	2003	124
17	Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity Vaccine ·Anke Huckriede,Laura Bungener,Wouter ter Veer,Marijke Holtrop,Toos Daemen,A.M. Palache,Jan Wilschut	2003	43
18	Immunogenicity and Reactogenicity of Influenza Subunit Vaccines Produced in MDCK Cells or Fertilized Chicken Eggs The Journal of Infectious Diseases ·A.M. Palache,Ruud Brands,G.J.M. van Scharrenburg	1997	90
19	Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies European Journal of Clinical Microbiology & Infectious Diseases ·W.E.P. Beyer,A.M. Palache,René Kerstens,N. Masurel	1996	72
20	Antibody induction by influenza vaccines in the elderly: a review of the literature Vaccine ·W.E.P. Beyer,A.M. Palache,Devereux N. Sailer,N. Masurel	1989	169

About A.M. Palache

A.M. Palache is a scholar working on Modeling and Simulation, Epidemiology and Health, having authored 59 papers that have together received 3.4k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (50 papers), Respiratory viral infections research (25 papers), SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 epidemiological studies (9 papers), Vaccine Coverage and Hesitancy (8 papers), Immune Response and Inflammation (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Epidemiology (2.7k citations), Immunology (1.1k citations) and Modeling and Simulation (244 citations). A.M. Palache has collaborated with scholars based in Netherlands, Belgium and Switzerland. Frequent co-authors include W.E.P. Beyer, Albert D. M. E. Osterhaus, J.C. de Jong, N. Masurel, Guus F. Rimmelzwaan, Jan Wilschut, Iris A. de Bruijn, G.J.M. van Scharrenburg, J. J. P. Nauta and Ruud Brands. Their work appears in journals such as Vaccine, Virus Research, Annals of the Rheumatic Diseases, Journal of Medical Virology and Advances in experimental medicine and biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact